- The use of a combination of tamoxifen and doxorubicin synergistically to induce cell cycle arrest in BT483 cells by down-regulating CDK1, CDK2 and cyclin D expression
Pei-Yun Chuang et al, 2013, journal of Pharmaceutical Technology and Drug Research CrossRef - Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro–In Silico Model
José Eduardo Vargas et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef - Chrysin Encapsulated Copper Nanoparticles with Low Dose of Gamma Radiation Elicit Tumor Cell Death Through p38 MAPK/NF-κB Pathways
Lubna O. Abdelhakm et al, 2023, Biological Trace Element Research CrossRef